Search

everythinglearnresearchcommunity

for

Search:↓

The study created a new method to test drugs that affect hormone processing in skin.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

Women with PCOS are more likely to have thyroid antibodies than those without.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

The trichogram is a practical, non-invasive, and cost-effective tool for diagnosing female androgenetic alopecia.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Thyroxine can adjust the body's peripheral clock, potentially helping treat clock-related diseases.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

The document corrects errors in a table about hair loss in women.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Hair samples can reliably show average long-term hormone levels in young women.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Dihydrotestosterone specifically binds to hamster sebaceous glands, with a higher affinity than testosterone.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Confirm testosterone levels with advanced tests to avoid unnecessary procedures.